Original Research

Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies

Jiang Y, Cai D, Shi S

Clinical Epidemiology 2022, 14:581-590

Published Date: 29 April 2022